Skip to main content
Top
Published in: AIDS Research and Therapy 1/2017

Open Access 01-12-2017 | Research

Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China

Authors: Rongrong Yang, Hong Zhang, Yong Xiong, Xien Gui, Yongxi Zhang, Liping Deng, Shicheng Gao, Mingqi Luo, Wei Hou, Deyin Guo

Published in: AIDS Research and Therapy | Issue 1/2017

Login to get access

Abstract

Background

CSF PCR is the standard diagnostic technique used in resource-rich settings to detect pathogens of the CNS infection. However, it is not currently used for routine CSF testing in China. Knowledge of CNS opportunistic infections among people living with HIV in China is limited.

Methods

Intensive cerebrospiral fluid (CSF) testing was performed to evaluate for bacterial, viral and fungal etiologies. Pathogen-specific primers were used to detect DNA from cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6) and John Cunningham virus (JCV) via real-time polymerase chain reaction (PCR).

Results

Cryptococcal meningitis accounted for 63.0% (34 of 54) of all causes of meningitis, 13.0% (7/54) for TB, 9.3% (5/54) for Toxoplasma gondii. Of 54 samples sent for viral PCR, 31.5% (17/54) were positive, 12 (22.2%) for CMV, 2 (3.7%) for VZV, 1 (1.9%) for EBV, 1 (1.9%) for HHV-6 and 1 (1.9%) for JCV. No patient was positive for HSV. Pathogen-based treatment and high GCS score tended to have a lower mortality rate, whereas patients with multiple pathogens infection, seizures or intracranial hypertension showed higher odds of death.

Conclusion

CNS OIs are frequent and multiple pathogens often coexist in CSF. Cryptococcal meningitis is the most prevalent CNS disorders among AIDS. The utility of molecular diagnostics for pathogen identification combined with the knowledge provided by the investigation may improve the diagnosis of AIDS related OIs in resource-limited developing countries, but the cost-efficacy remains to be further evaluated.
Literature
1.
go back to reference Weisberg LA. Neurologic abnormalities in human immunodeficiency virus infection. South Med J. 2001;94(3):266–75.CrossRefPubMed Weisberg LA. Neurologic abnormalities in human immunodeficiency virus infection. South Med J. 2001;94(3):266–75.CrossRefPubMed
2.
go back to reference Levy RM, Bredesen DE. Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr. 1988;1(1):41–64.PubMed Levy RM, Bredesen DE. Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr. 1988;1(1):41–64.PubMed
3.
go back to reference Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998. Neurology. 2001;56(2):257–60.CrossRefPubMed Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998. Neurology. 2001;56(2):257–60.CrossRefPubMed
4.
go back to reference Bhigjee AI, Naidoo K, Patel VB, Govender D. Intracranial mass lesions in HIV-positive Patients-the KwaZulu/Natal experience. Neuroscience AIDS Research Group. S Afr Med J. 1999;89(12):1284–8.PubMed Bhigjee AI, Naidoo K, Patel VB, Govender D. Intracranial mass lesions in HIV-positive Patients-the KwaZulu/Natal experience. Neuroscience AIDS Research Group. S Afr Med J. 1999;89(12):1284–8.PubMed
5.
go back to reference Fragoso YD, Mendes V, Adamo AP, Bosco LP, Tavares CA. Neurologic manifestations of AIDS: a review of fifty cases in Santos, Sao Paulo, Brazil. Sao Paulo Med J. 1998;116(3):1715–20.CrossRefPubMed Fragoso YD, Mendes V, Adamo AP, Bosco LP, Tavares CA. Neurologic manifestations of AIDS: a review of fifty cases in Santos, Sao Paulo, Brazil. Sao Paulo Med J. 1998;116(3):1715–20.CrossRefPubMed
6.
go back to reference Isezuo SA, Sani AZ, Ezunu E, Maiyaki S, Njoku CH, Obembe A. Clinical neuropathy in HIV/AIDS: an eight-year review of hospitalized patients in Sokoto, northwestern Nigeria. Trop Doct. 2009;39(3):133–5.CrossRefPubMed Isezuo SA, Sani AZ, Ezunu E, Maiyaki S, Njoku CH, Obembe A. Clinical neuropathy in HIV/AIDS: an eight-year review of hospitalized patients in Sokoto, northwestern Nigeria. Trop Doct. 2009;39(3):133–5.CrossRefPubMed
7.
go back to reference Modi M, Mochan A, Modi G. Management of HIV-associated focal brain lesions in developing countries. QJM. 2004;97(7):413–21.CrossRefPubMed Modi M, Mochan A, Modi G. Management of HIV-associated focal brain lesions in developing countries. QJM. 2004;97(7):413–21.CrossRefPubMed
8.
go back to reference World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2007. p. 10–38. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization; 2007. p. 10–38.
9.
go back to reference Bekondi C, Bernede C, Passone N, Minssart P, Kamalo C, Mbolidi D, et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis. 2006;10(5):387–95.CrossRefPubMed Bekondi C, Bernede C, Passone N, Minssart P, Kamalo C, Mbolidi D, et al. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis. 2006;10(5):387–95.CrossRefPubMed
10.
go back to reference Cohen DB, Zijlstra EE, Mukaka M, Reiss M, Kamphambale S, Scholing M, et al. Diagnosis of crytococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health. 2010;15(8):910–7.CrossRefPubMed Cohen DB, Zijlstra EE, Mukaka M, Reiss M, Kamphambale S, Scholing M, et al. Diagnosis of crytococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health. 2010;15(8):910–7.CrossRefPubMed
11.
go back to reference Bisson GP, Lukes J, Thakur R, Mtoni I, MacGregor RR. Cryptococcus and lymphocytic meningitis in Botswana. S Afr Med J. 2008;98(9):724–5.PubMed Bisson GP, Lukes J, Thakur R, Mtoni I, MacGregor RR. Cryptococcus and lymphocytic meningitis in Botswana. S Afr Med J. 2008;98(9):724–5.PubMed
13.
go back to reference Siddiqi OK, Ghebremichael M, Dang X, Atadzhanov M, Kaonga P, Khoury MN, et al. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014;58:1771–7.CrossRefPubMedPubMedCentral Siddiqi OK, Ghebremichael M, Dang X, Atadzhanov M, Kaonga P, Khoury MN, et al. Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis. 2014;58:1771–7.CrossRefPubMedPubMedCentral
14.
go back to reference Akinbami AA, Akanmu AS, Adeyemo TA, Wright KO, Dada MO, Dosunmu AO. Cytomegalovirus anti-bodies among healthy blood donors at Lagos University Teaching Hospital. S Afr Med J. 2009;99(7):528–30. Akinbami AA, Akanmu AS, Adeyemo TA, Wright KO, Dada MO, Dosunmu AO. Cytomegalovirus anti-bodies among healthy blood donors at Lagos University Teaching Hospital. S Afr Med J. 2009;99(7):528–30.
15.
go back to reference Spector SA, Wong R, Hsia K, et al. Plasma cytomegalovirus(CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest. 1998;101:497–502.CrossRefPubMedPubMedCentral Spector SA, Wong R, Hsia K, et al. Plasma cytomegalovirus(CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest. 1998;101:497–502.CrossRefPubMedPubMedCentral
16.
go back to reference Fowotade A, Okonko IO, Agbede OO, Suleiman ST. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin. Nigeria. Afr Health Sci. 2015;15(1):1–9.CrossRefPubMed Fowotade A, Okonko IO, Agbede OO, Suleiman ST. High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin. Nigeria. Afr Health Sci. 2015;15(1):1–9.CrossRefPubMed
17.
go back to reference Kotler DP, Reka S, Borcich A, Cronin WJ. Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. Am J Pathol. 1991;139:823–30.PubMedPubMedCentral Kotler DP, Reka S, Borcich A, Cronin WJ. Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. Am J Pathol. 1991;139:823–30.PubMedPubMedCentral
18.
go back to reference Manzardo C, Del Mar Ortega M, Sued O, Garcia F, Moreno A, Miro JM. Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol. 2005;11(suppl 3):72–82.CrossRefPubMed Manzardo C, Del Mar Ortega M, Sued O, Garcia F, Moreno A, Miro JM. Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol. 2005;11(suppl 3):72–82.CrossRefPubMed
19.
go back to reference Kelly MJ, Benjamin LA, Cartwright K, et al. Epstein-Barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis. J Infect Dis. 2012;205:106–10.CrossRefPubMed Kelly MJ, Benjamin LA, Cartwright K, et al. Epstein-Barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis. J Infect Dis. 2012;205:106–10.CrossRefPubMed
20.
go back to reference Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African population. AIDS. 2001;15(suppl 4):s97–108.CrossRefPubMed Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African population. AIDS. 2001;15(suppl 4):s97–108.CrossRefPubMed
21.
go back to reference Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435–46.CrossRefPubMed Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435–46.CrossRefPubMed
22.
go back to reference Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;4:CD009593. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;4:CD009593.
24.
go back to reference Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. Modeling of novel diagnostic strategies for active tuberculosis-a systematic review: current practices and recommendations. PLoS ONE. 2014;9:e110558.CrossRefPubMedPubMedCentral Zwerling A, White RG, Vassall A, Cohen T, Dowdy DW, Houben RM. Modeling of novel diagnostic strategies for active tuberculosis-a systematic review: current practices and recommendations. PLoS ONE. 2014;9:e110558.CrossRefPubMedPubMedCentral
25.
go back to reference Langley I, Lin HH, Squire SB. Cost-effectiveness of Xpert MTB/RIF and investing in health care in African. Lancet Glob Health. 2015;3:e83–4.CrossRefPubMed Langley I, Lin HH, Squire SB. Cost-effectiveness of Xpert MTB/RIF and investing in health care in African. Lancet Glob Health. 2015;3:e83–4.CrossRefPubMed
26.
go back to reference Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013;13:349–61.CrossRefPubMedPubMedCentral Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013;13:349–61.CrossRefPubMedPubMedCentral
27.
go back to reference Creswell J, Codlin AJ, Andre E, et al. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC Infect Dis. 2014;14:2.CrossRefPubMedPubMedCentral Creswell J, Codlin AJ, Andre E, et al. Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC Infect Dis. 2014;14:2.CrossRefPubMedPubMedCentral
28.
go back to reference Cowan JF, Michel C, Manhica I, et al. Implementing rapid testing for tuberculosis in Mozambique. Bull World Health Organ. 2015;93:125–30.CrossRefPubMed Cowan JF, Michel C, Manhica I, et al. Implementing rapid testing for tuberculosis in Mozambique. Bull World Health Organ. 2015;93:125–30.CrossRefPubMed
29.
30.
go back to reference Cowan JF, Chandler AS, Kracen E, Park DR, Wallis CK, Liu E, Song C, Persing DH, Fang FC. Clinical impact and cost-effectiveness of Xpert MTB/RIF testing in hospitalized patients with presumptive pulmonary tuberculosis in the United States. Clin Infect Dis. 2017;64(4):482–9.PubMed Cowan JF, Chandler AS, Kracen E, Park DR, Wallis CK, Liu E, Song C, Persing DH, Fang FC. Clinical impact and cost-effectiveness of Xpert MTB/RIF testing in hospitalized patients with presumptive pulmonary tuberculosis in the United States. Clin Infect Dis. 2017;64(4):482–9.PubMed
Metadata
Title
Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China
Authors
Rongrong Yang
Hong Zhang
Yong Xiong
Xien Gui
Yongxi Zhang
Liping Deng
Shicheng Gao
Mingqi Luo
Wei Hou
Deyin Guo
Publication date
01-12-2017
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2017
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-017-0150-2

Other articles of this Issue 1/2017

AIDS Research and Therapy 1/2017 Go to the issue